Buscar
Mostrando ítems 31-40 de 1337
Respiratory Syncytial Virus Seasonality In Brazil: Implications For The Immunisation Policy For At-risk Populations
(Fundação Oswaldo Cruz, Escola Politécnica Saúde Joaquim VenâncioRio de Janeiro, 2016)
Respiratory syncytial virus: occurrence of subgroups A and B strains in Rio de Janeiro
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz., 2020)
Characterization of Respiratory Syncytial Viruses circulating in the northeast Brazilian region: epidemiological and molecular surveillance within the Influenza surveillance program
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2018)
Potential Neurocognitive Consequences Of Infection By Human Respiratory Syncytial Virus
(2016)
Human respiratory syncytial virus (RSV) infection remains as a major cause of morbidity and mortality among pediatric population. Immune response is poor and unable to establish a long term effective protection against ...
Immunological Features Of Respiratory Syncytial Virus-Caused Pneumonia-Implications For Vaccine Design
(2017)
The human respiratory syncytial virus (hRSV) is the causative agent for high rates of hospitalizations due to viral bronchiolitis and pneumonia worldwide. Such a disease is characterized by an infection of epithelial cells ...
A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus
(2017)
The human Respiratory Syncytial Virus (hRSV) causes lower respiratory tract infections including pneumonia and bronchiolitis. Such infections also cause a large number of hospitalizations and affects mainly newborns, young ...
Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design
(2017)
The human respiratory syncytial virus (hRSV) is the causative agent for high rates of hospitalizations due to viral bronchiolitis and pneumonia worldwide. Such a disease is characterized by an infection of epithelial cells ...
Heme Oxygenase-1 Modulates Human Respiratory Syncytial Virus Replication and Lung Pathogenesis during Infection
(2017)
Human respiratory syncytial virus (hRSV) is the leading cause of severe lower respiratory tract infections in children. The development of novel prophylactic and therapeutic antiviral drugs against hRSV is imperative to ...
Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design
(2017)
The human respiratory syncytial virus (hRSV) is the causative agent for high rates of hospitalizations due to viral bronchiolitis and pneumonia worldwide. Such a disease is characterized by an infection of epithelial cells ...